This inventor holds 20 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents, primarily in Neurodegenerative Diseases. Top assignees: Acadia Pharmaceuticals Inc., Verenium Corporation. Active years: 2002-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2020
Areas of Expertise:
Title: David M Weiner: Innovator in Neurodegenerative Disease Therapeutics
Introduction
David M Weiner, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of pharmacology, particularly in developing novel therapeutics for neurodegenerative diseases. With a notable tally of 20 patents, his work showcases a dedication to improving the quality of life for individuals suffering from mental health disorders and movement-related issues.
Latest Patents
One of David's latest patents focuses on selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases. The compound of formula (I) demonstrated in vivo efficacy in models of psychosis and dyskinesias. Behavioral pharmacological data reveal that this compound shows promise as an efficacious anti-psychotic by reversing MK-801 induced locomotor behaviors. Additionally, it has shown activity in an MPTP primate model of dyskinesias, indicating potential efficacy as an anti-dyskinesia agent. These findings support the hypothesis that 5HT2A/2C receptor inverse agonism may provide antipsychotic and anti-dyskinetic benefits in humans, suggesting the use of the compound and related agents as innovative therapeutics for Parkinson's disease and other related neurodegenerative disorders.
Career Highlights
David Weiner has had an impressive career, notably working with Acadia Pharmaceuticals Inc., a company at the forefront of developing and commercializing innovative medicines to address unmet medical needs. His role in advancing research and patents related to neuropharmacology highlights his commitment to the field and his innovative mindset.
Collaborations
Collaboration has been key to David's success. He has worked alongside notable colleagues such as Mark R Brann and Robert E Davis, contributing to collective advancements in drug development and therapeutic applications. Such partnerships enrich the research process and enhance the prospects for future breakthroughs.
Conclusion
David M Weiner is a distinguished inventor whose work has the potential to transform treatment paradigms for neurodegenerative diseases and associated mental health conditions. Through his numerous patents and collaborative efforts, he demonstrates the impactful role that innovators play in advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile